From October 1, 2023 to December 31, 2023, the company has repurchased 20,000 shares, representing 0.02% for CNY 1.07 million. With this, the company has completed the repurchase of 29,829 shares, representing 0.02% for CNY 1.59 million under the buyback announced on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.46 CNY | -3.20% | -7.02% | -20.88% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.88% | 854M | |
+55.10% | 811B | |
+43.62% | 640B | |
-7.12% | 353B | |
+17.91% | 333B | |
+8.90% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.57% | 168B |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.